{"id":74720,"date":"2020-09-30T18:11:00","date_gmt":"2020-09-30T18:11:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2736278"},"modified":"2020-09-30T18:11:00","modified_gmt":"2020-09-30T18:11:00","slug":"total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/","title":{"rendered":"Total number of shares and voting rights in Zealand Pharma at September 30, 2020"},"content":{"rendered":"<p><img decoding=\"async\" width=\"233\" height=\"24\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p>Zealand Pharma A\/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers&#8217; Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.&nbsp;<\/p>\n<p align=\"justify\">In Company announcement No. 48\/2020 from September 11, 2020, Zealand announced an increase in share capital relating to the exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand up to and including September 30, 2020:<\/p>\n<table class=\"gnw_table_border_collapse hugin\">\n<tbody>\n<tr>\n<td class=\"gnw_border_top_solid gnw_border_right_solid gnw_border_bottom_solid gnw_border_left_solid hugin gnw_vertical_align_top\"><strong>&nbsp;<\/strong><\/p>\n<p><strong>Date<\/strong><\/td>\n<td class=\"gnw_border_top_solid gnw_border_right_solid gnw_border_bottom_solid gnw_align_center hugin gnw_vertical_align_top\"><strong>Number of shares<\/strong><br \/><strong>(nominal value of DKK 1 each)<\/strong><\/td>\n<td class=\"gnw_border_top_solid gnw_border_right_solid gnw_border_bottom_solid gnw_align_center hugin gnw_vertical_align_top\"><strong>Share capital<\/strong><br \/><strong>(nominal value in DKK)<\/strong><\/td>\n<td class=\"gnw_border_top_solid gnw_border_right_solid gnw_border_bottom_solid gnw_align_center hugin gnw_vertical_align_top\"><strong>Number of voting rights<\/strong><\/td>\n<\/tr>\n<tr>\n<td class=\"gnw_border_right_solid gnw_border_bottom_solid gnw_border_left_solid hugin gnw_vertical_align_top\">September 30, 2020<\/td>\n<td class=\"gnw_border_right_solid gnw_border_bottom_solid gnw_align_center hugin gnw_vertical_align_top\">39,778,961<\/td>\n<td class=\"gnw_border_right_solid gnw_border_bottom_solid gnw_align_center hugin gnw_vertical_align_top\">39,778,961<\/td>\n<td class=\"gnw_border_right_solid gnw_border_bottom_solid gnw_align_center hugin gnw_vertical_align_top\">39,778,961<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"center\"># # #<\/p>\n<p align=\"justify\"><strong>About Zealand Pharma A\/S<\/strong><br \/>Zealand Pharma is a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand&rsquo;s robust pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand markets V-Go<sup>&reg;<\/sup>, an all-in-one basal-bolus insulin delivery option for people with diabetes. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics.<\/p>\n<p align=\"justify\">Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA). For more information about Zealand&rsquo;s business and activities, please visit&nbsp;www.zealandpharma.com. &nbsp;<\/p>\n<p><strong>Forward-Looking Statement<\/strong><\/p>\n<p align=\"justify\">The above information contains forward-looking statements that provide Zealand Pharma&rsquo;s expectations or forecasts of future events. Such forward-looking statements are subject to risks, uncertainties and inaccurate assumptions, which may cause actual results to differ materially from expectations set forth herein and may cause any or all of such forward-looking statements to be incorrect. If any or all of such forward-looking statements prove to be incorrect, our actual results could differ materially and adversely from those anticipated or implied by such statements. All such forward-looking statements speak only as of the date of this release and are based on information available to Zealand Pharma as of the date of this release.<\/p>\n<p><strong>For further information, please contact:<\/strong><\/p>\n<p>Mads Kronborg<br \/>Head of Investor Relations &amp; Communication<br \/>Phone: +45 5060 3707<br \/>Email:&nbsp;mkronborg@zealandpharma.com<\/p>\n<p><strong>For U.S. Media<\/strong><br \/>David Rosen<br \/>Argot Partners<br \/>Phone: 212-600-1902<br \/>Email: media@zealandpharma.com<\/p>\n<p class=\"tags\">\n<div><strong>See Campaign: <\/strong><a href=\"http:\/\/zealandpharma.com\" target=\"_blank\">http:\/\/zealandpharma.com<\/a><br \/><b>Contact Information:<\/b><br \/>Mads Kronborg<br \/>\nHead of Investor Relations &#038; Communication<br \/>\nPhone: +45 5060 3707<br \/>\nEmail:mkronborg@zealandpharma.com<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/wire\/\" rel=\"category tag\">Wire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/disclosure-newswire\/\" rel=\"category tag\">Disclosure Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/global-regions\/united-states\/\" rel=\"category tag\">United States<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Mads Kronborg<br \/>\nHead of Investor Relations &#038; Communication<br \/>\nPhone: +45 5060 3707<br \/>\nEmail:\u00a0mkronborg@zealandpharma.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"233\" height=\"24\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png\" alt=\"\">Zealand Pharma A\/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers&rsquo; Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\">Continue reading <span>Total number of shares and voting rights in Zealand Pharma at September 30, 2020<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":46,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56,3,22,54],"tags":[],"class_list":["post-74720","post","type-post","status-publish","format-standard","hentry","category-disclosure-newswire","category-english","category-united-states","category-wire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Total number of shares and voting rights in Zealand Pharma at September 30, 2020 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Total number of shares and voting rights in Zealand Pharma at September 30, 2020 - Business\" \/>\n<meta property=\"og:description\" content=\"Zealand Pharma A\/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers&rsquo; Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been &hellip; Continue reading Total number of shares and voting rights in Zealand Pharma at September 30, 2020 Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-30T18:11:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png\" \/>\n<meta name=\"author\" content=\"Asiya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asiya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\",\"name\":\"Total number of shares and voting rights in Zealand Pharma at September 30, 2020 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png\",\"datePublished\":\"2020-09-30T18:11:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Total number of shares and voting rights in Zealand Pharma at September 30, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37\",\"name\":\"Asiya\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g\",\"caption\":\"Asiya\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/asiya\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Total number of shares and voting rights in Zealand Pharma at September 30, 2020 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/","og_locale":"en_US","og_type":"article","og_title":"Total number of shares and voting rights in Zealand Pharma at September 30, 2020 - Business","og_description":"Zealand Pharma A\/S, a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers&rsquo; Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been &hellip; Continue reading Total number of shares and voting rights in Zealand Pharma at September 30, 2020 Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/","og_site_name":"Business","article_published_time":"2020-09-30T18:11:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png","type":"","width":"","height":""}],"author":"Asiya","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asiya","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/","url":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/","name":"Total number of shares and voting rights in Zealand Pharma at September 30, 2020 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png","datePublished":"2020-09-30T18:11:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-logo.png"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2020\/09\/30\/total-number-of-shares-and-voting-rights-in-zealand-pharma-at-september-30-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Total number of shares and voting rights in Zealand Pharma at September 30, 2020"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37","name":"Asiya","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g","caption":"Asiya"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/asiya\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/74720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=74720"}],"version-history":[{"count":0,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/74720\/revisions"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=74720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=74720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=74720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}